Centre moves to reduce costs of trastuzumab deruxtecan, osimertinib & durvalumab, all 3 by British-Swedish pharma giant AstraZeneca. Doctors seek exemptions for more such drugs.
Likely to be presented to Cabinet before being tabled in Parliament, latest version of draft bill aims to regulate, restrict or ban online sale of prescription drugs.
In a statement, Biological E. said it plans to manufacture 75 million doses a month, anticipating more than 100 million doses per month by February 2022.
The vaccine Dengvaxia has to be administered to individuals aged 9 to 45, who have been infected with the dengue virus before and who live in areas where this infection is endemic.
The Modi govt must not damage India’s competitive advantage in vaccines & pharmaceuticals through absurd benchmarks that will not be trusted by other countries.
Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.
The enhanced budget helps, but internal stock-taking and preliminary steps have to be taken before the tagline Sahkar Se Samriddhi—from co-operation to prosperity—becomes a reality.
Armenia has procured significant defence equipment from India, including artillery guns, multi-barrel rocket launchers, air defence system, sniper rifles, weapons locating radars, anti-drone weapons.
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.
COMMENTS